Evidence map›Paper›PMID 41598574›Full record

ArticleJournal of clinical medicine2026

SCUBE-1 as a Biomarker Predictor for the Home Follow-Up and Hospitalization of SARS-CoV-2 Patients.

Selçuk Eren Çanakçi, Kenan Ahmet Turkdogan, Mustafa Kerem Ozyavuz, Faruk Celik, Mehmet Mesut Sonmez, Ibrahim Yilmaz, Ali Osman Arslan, Abdullah Emre Güner, Şakir Ümit Zeybek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Selçuk Eren ÇanakçiDepartment of Emergency Medicine, Alaaddin Keykubat University, 07425 Alanya, Turkey.ORCID 0000-0002-2795-0714
Kenan Ahmet TurkdoganDepartment of Emergency Medicine, Alaaddin Keykubat University, 07425 Alanya, Turkey.
Mustafa Kerem OzyavuzDepartment of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, 34452 Istanbul, Turkey.ORCID 0000-0001-6656-5264
Faruk CelikDepartment of Medical Genetics, Alaaddin Keykubat University, 07425 Alanya, Turkey.ORCID 0000-0003-2433-0277
Mehmet Mesut SonmezDepartment of Orthopedics and Traumatology, Istanbul Haseki Training and Research Hospital, University of Health Sciences, 34734 Istanbul, Turkey.
Ibrahim YilmazDepartment of Biochemistry, Haseki Training and Research Hospital, Health Sciences University, 34096 Istanbul, Turkey.
Ali Osman ArslanDepartment of Medical Biology, Bolu Abant Izzet Baysal University Medical Faculty, 14280 Bolu, Turkey.ORCID 0000-0002-5711-0038
Abdullah Emre GünerDepartment of Public Health, Hamidiye Faculty of Medicine, University of Health Sciences, 34734 Istanbul, Turkey.ORCID 0000-0001-8624-4468
Şakir Ümit ZeybekDepartment of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, 34452 Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical outcomesCOVID-19 severity assessmentemergency department triageinflammatory biomarkersneutrophil-to-lymphocyte ratio (NLR)

Identifiers

PMID41598574
PMCPMC12842058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.